ArticleNature2023
γδ T cells are effectors of immunotherapy in cancers with HLA class I defects.
Natasja L de Vries et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
214 papers cite itlatest 60 shown
this papertrialcites it
ArticleNature2023
Natasja L de Vries et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.